We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Blood and blood components (including haematopoietic progenitor cells ), are regulated under the Therapeutic Goods Act 1989 as medicines. Plasma-derived medical products are regulated as prescription medicines.